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doi:10.1016/j.kjms.2010.07.003Abstract Glomerular involvement in patients with primary Sjo¨gren’s syndrome (pSS) has
rarely been reported. Among them, membranoproliferative glomerulonephritis and membra-
nous nephropathy are the more common types. We report a middle-aged female presenting
concurrently with nephrotic syndrome and microscopic hematuria, and her pSS was diagnosed
by positive anti-Ro (SSA)/anti-La (SSB) autoantibodies, dry mouth, severely diffuse impaired
function of both bilateral parotid and submandibular glands, and a positive Schirmer test.
Renal pathology revealed minimal change disease and thin basement membrane nephropathy.
The patient’s nephrotic syndrome resolved after treatment with corticosteroids. To our knowl-
edge, this is the first report of minimal change disease in a patient with pSS.
摘要 過去很少有關於原發性休葛蘭症候群合併腎絲球疾病的報告。其中，又以膜性增殖性腎絲
球腎炎及膜狀腎絲球腎炎比例最多。本報告報導一位中年女性因雙下肢水腫而就醫，經診斷為腎
病症候群，又因其anti-Ro (SSA)/anti-La (SSB)自體免疫抗體呈陽性反應，嘴巴乾燥，雙側耳下腺
及頷下腺呈彌漫性功能受損，且經Schirmer test診斷為乾眼症，其他檢驗結果顯示無其他結締組
織疾病。因此，診斷此病人罹患原發性休葛蘭症候群。腎臟切片檢查顯示其腎臟有微小變化症腎
炎及薄基底膜病變。此病人經類固醇治療後，腎病症候群之症狀已大有改善。這是首例原發性休
葛蘭症候群合併微小變化症腎炎的報告。
Copyright ª 2011, Elsevier Taiwan LLC. All rights reserved.ephrology, Department of Internal Medicine, Kaohsiung Medical University Hospital, No. 100, Tzyou
tw (H.-C. Chen).
vier Taiwan LLC. All rights reserved.
Sjo¨gren’s syndrome and minimal change disease 191Introduction She denied any systemic diseases or specific medicationSjo¨gren’s syndrome (SS) is an autoimmune disease character-
ized by mononuclear cell infiltration of exocrine tissues and
autoantibodies against the ribonucleoprotein particles Ro/SSA
andLa/SSB. PrimarySS (pSS) is distinguished fromsecondary SS
by the absence of other autoimmune diseases, such as rheu-
matoid arthritis, systemic sclerosis, systemic lupus eryth-
ematosus [1]. Because of the different criteria for diagnosing
pSS and the small groups of patients studied for renal
involvement in the previous literature, the reported preva-
lence of renal manifestations in pSS varies widely from 2% to
67% [2e5]. Among them, tubulointerstitial nephritis resulting
in latent or overt tubular abnormalities compromised major
renal involvement in pSS and may manifest as Type 1 renal
tubular acidosis, nephrogenic diabetes insipidus, hypokalemia
without renal tubular acidosis, or Fanconi syndrome [6e10].
However, glomerular involvement in patients with pSS has
rarely been reported (Table 1) [3,11e22]. Among them,
membranoproliferative glomerulonephritis and membranous
nephropathyarethemorecommontypes.The small numberof
case reports limits our knowledge of the biochemical markers,
pathogenesis, and treatment of glomerular diseases associ-
ated with pSS. In the report, we present the first case of
minimal change disease (MCD) associated with pSS. The
research concerning this subject is also discussed.
Case presentation
A 40-year-old woman was admitted because of general
edema for 3 months and intermittent attack of dry mouth.Table 1 Summary of glomerulonephritis in previously reported
Reference Glom
Current case Minimal change disease
Chen et al. [11]
Guillot et al. [12]
IgA nephropathy
Membranous nephropat
Stefanidis et al. [13] Membranous nephropat
Ren et al. [14] Membranous nephropat
Membranoproliferative
Focal segmental glome
Mesangioproliferative g
Tsai et al. [15] IgA nephropathy
Kau et al. [16] Cryoglobulinemic glome
Watanabe et al. [17] IgA nephropathy
Bossini et al. [3] Membranous nephropat
Membranoproliferative
Mesangioproliferative g
Goules et al. [7] Membranoproliferative
Mesangioproliferative g
Cortez et al. [18] Membranoproliferative
Dussol et al. [19] Crescentic glomerulone
Khan et al. [20] Membranoproliferative
Siamopoulos et al. [21] Membranous nephropat
Membranoproliferative
Moutsopoulos et al. [22] Membranoproliferative
Membranous nephropattaken previously, including analgesics and Chinese herbs.
On admission, the vital signs showed blood pressure of 110/
70 mmHg, pulse rate of 84/min, respiratory rate of 16e18/
min, and body temperature of 37.2C. The physical exam-
ination only revealed obvious edema over the bilateral
lower limbs and mild dryness over the oral mucosa. Labo-
ratory tests revealed a serum albumin of 1.79 g/dL and
a cholesterol level of 304 mg/dL. The daily urine protein
loss was 6.35 g. Serum creatinine was 0.78 mg/dL (creati-
nine clearance 87.6 mL/min) and blood urea nitrogen was
12.8 mg/dL. Her liver function was normal. The white blood
cell count was 4,600/mL and hemoglobin level was 12.3 g/
dL. Analysis of venous blood gas showed pH 7.352, HCO3
28.4 mEq/L, and pCO2 52.5 mmHg. The serum electrolyte
levels were Naþ 138 mEq/L, Kþ 4.2 mEq/L, Ca2þ 4.65 mg/
dL, Mg2þ 2.33 mg/dL, and phosphate 4.2 mg/dL. Further
laboratory studies showed mild elevation of immunoglob-
ulin A level (IgA: 461 mg/dL, IgG: 905 mg/dL, IgM: 162 mg/
dL), negative antiglomerular basement membrane anti-
body, normal antistreptolysin O titer, negative anti-
neutrophil cytoplasmic antibodies, normal b2-microglobulin
level (350 mg/dL), and negative indicators for hepatitis B
and C markers. The evaluation of serum complement
showed normal C3 level (82.9 mg/dL) and slightly
decreased C4 level (13 mg/dL). There was no monoclonal
component or hypergammaglobulinemia shown by serum
and urine immunofixation electrophoresis examination. The
serum antinuclear antibody titer was 1:320 (speckled type),
and anti-ds DNA was negative. Positive anti-Ro (SSA,
>240 U/mL)/anti-La (SSB, 35.6 U/mL) autoantibodies were
subsequently found. Urinalysis showed pH 6.0, specificpatients with Sjo¨gren’s syndrome
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Figure 1. Light microscopy showing unremarkable change in
glomerulus and renal tubules. (A) Hematoxylin-eosin staining,
magnification200. (B) Periodic acid Schiff, magnifica-
tion200. Electron microscopy showing the effacement of foot
processes and thin basement membrane with a thickness of
270 46 nm, without electron dense deposits. (C) Transmission
electron microscopy, magnification  4,000.
192 M.-L. Yang et al.gravity of 1.015, microscopic hematuria (red blood cell
3e5/high power field), heavy proteinuria (protein 4þ), and
absence of glucosuria. pSS was finally diagnosed according
to positive anti-Ro/anti-La autoantibodies, dry mouth with
severely diffuse impaired function of the bilateral parotid
and submandibular glands revealed by salivary scintigraphy,
and positive Schirmer test. Further evaluation showed no
evidence of association with other connective tissue
diseases or renal tubular acidosis.
Renal biopsy was performed to evaluate the cause of
nephrotic syndrome. The specimen contained 22
glomeruli. The immunofluorescent studies did not show
reaction to any of the IgG, IgA, IgM, C3, C4, and heavy or
light chains. Light microscopy revealed unremarkable
changes over the glomerulus, tubules, and interstitium.
Electron microscopy showed diffuse effacement of the foot
processes without electron dense deposits. The glomerular
capillary basement membranes were relatively thin with
a thickness of 270 46 nm (Fig. 1). These findings were
consistent with MCD and thin basement membrane
nephropathy (TBMN). Ultimately, the patient’s nephrotic
syndrome was resolved gradually after treatment with
glucocorticoid.
Discussion
Renal involvement is one of the extraglandular manifesta-
tions of pSS, although the true prevalence and types of
renal diseases are unclear. Some previous studies on renal
involvement did not distinguish primary from secondary SS,
making it difficult to clarify whether renal involvement
contributed to SS per se or to other associated disorders.
Therefore, early diagnosis is important for understanding
the effects of pSS on renal disorder. The present case of pSS
was diagnosed based on the positive anti-Ro/anti-La auto-
antibodies, dry mouth, and positive findings in the salivary
scintigraphy, and Schirmer test, fulfilling the European
American co-criteria of 2002 [23].
Renal involvement in SS is usually limited to the tubu-
lointerstitium, with mainly the distal renal tubular acidosis
(dRTA) in a reported incidencebetween5%and70% [2e4,14].
The high percentage of patients with dRTA suggests pSS may
have important contributions to tubular damages. Glomer-
ular involvement in pSS is far less common than the tubu-
lointerstitium, and the manifestations might be hematuria,
proteinuria, or even nephrotic syndrome. In a study by Bos-
sini et al. [3], the incidence of glomerular lesionwas 5%. In 62
patientswithpSS reportedbyAasarødet al. [2], only one case
(1.6%) of glomerular involvement was found. A higher inci-
dence of 13.6% of glomerular involvement in pSS was also
reported by Ren et al. [14]. As summarized in Table 1,
common glomerular diseases associated with pSS were
membranoproliferative glomerulonephritis, membranous
nephropathy, and mesangioproliferative glomerulonephritis
[3,7,12e14,18,20e22]. Moreover, few cases with IgA
nephropathy and focal segmental glomerulosclerosis were
also reported [11,14,15,17]. MCD, as in our case, was not
found in the literature. Glomerular involvement in pSS was
associated with older age, longer courses of renal impair-
ment, higher occurrence of late stage of the disease, and
higher morbidity and mortality [7]. Thus, the glomerular
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rarer incidence than tubulointerstitial involvement. In the
classical manifestations of SS, renal diseases were consid-
ered to precede the onset of subjective sicca syndrome.
However, Bossini et al. [3] and Tu et al. [10] reported the
renal diseases antedated by months or even years of the
onset of ocular, oral, or articular abnormalities. In present
case, nephrotic syndrome also antedated the subjective
symptom of dry mouth. The effects of this timing sequence
on the disease prognosis require further evaluation.
However, it is clear that serological and imaging evidence for
SS should be worked out in patient with unexplained
nephrotic syndrome or tubulointerstitial disease, even
without subjective sicca syndrome.
The pathogenesis of renal involvement in pSS remains
unclear. High levels of serum b2-microglobulin, hyper-
gammaglobulinemia, and positive anti-SSA/anti-SSB have
been suggested to be associated with dRTA in SS
[2,13,14,24]. Urinary b2-microglobulin, N-acetyl-b-gluco-
saminidase and alkaline phosphatase were also significantly
higher in patients with dRTA [2]. On the other hand,
deposits of circulating immune complex were thought to be
the key factor for developing glomerular diseases. Mixed
cryoglobulinaemia and decreased complement C4 were
assumed to be significant predictors for developing
glomerular diseases in pSS [2,3,7,14,25]. Additionally,
Ioannidis et al. [26] showed that low C4 level was an
independent predictor of lymphoproliferation, and The-
ander et al. [27] found that patients with low C4 levels had
an increased mortality for lymphoproliferative disease as
well as an increased hazard ratio for death. Our case,
without lymphoproliferative disease, did not show cry-
oglobulinemia, but the C4 level was slightly decreased.
Because of the limited case reports and the controversial
results of previous studies, the associations between these
serological markers and glomerular involvements or lym-
phoproliferative disease in pSS require more studies to be
clarified. As a bridge between activated B cells and
defective T cells, IgA plays a pivotal role in the pathogen-
esis of SS. High levels of serum and secretary IgA, IgA-
rheumatoid factor, and IgA-containing circulating immune
complexes were reported in previous studies [28]. Addi-
tionally, saliva IgA autoantibody, against M3 muscarinic
acetylcholine receptor, was shown to be implicated in the
pathophysiology of dry mouth in pSS [29]. However, the
importance of the slightly elevated serum IgA level related
to dry mouth or glomerular disease in our case needs
further evaluation.
Immune complexes may result in glomerular deposition
and play a key role in glomerular disease. Nevertheless, SS
is a multifaceted autoimmune disease with an intercon-
nection among different effector T cells, B lymphocytes
and antigen-presenting cells. Progressive lymphocyte infil-
tration, with the highest numbers of CD4þ T helper cells
and a lesser numbers of B cells, is often seen in salivary
lacrimal glands during the development of SS, especially
during the early stage and the very late stage of disease
[30]. Diffuse infiltration of the interstitium by lymphocytes
and plasma cells were implicated in interstitial nephritis in
pSS. However, it is still unclear whether T-cell abnormali-
ties cause pSS-associated glomerular disease as MCD. In
our patient with nephritic syndrome and microscopichematuria, the histological diagnosis was made of MCD
associated with TBMN. TBMN, an autosomal dominant
disease with excellent prognosis, is characterized by
hematuria, minimal proteinuria, normal renal function, and
another family member with hematuria. Nogueira et al.
[31] described adults with TBMN having microscopic
hematuria with heavy proteinuria or nephritic syndrome
and concluded that nephritic syndrome might be caused by
an associated MCD in some patients with TBMN. This finding
is in accordance with the current case. We speculate,
therefore, that the nephrotic-range proteinuria in our case
is not because of TBMN but rather the manifestation of
MCD. However, her family history of benign hematuria for
TBMN should be evaluated. Additionally, more accumulated
cases are necessary to elucidate whether MCD-super-
imposed TBMN is just a mere coincidence in the case or
there is causal relationship between pSS and kidney
disease.
In summary, we present the first case of MCD associated
with thin basement membrane nephropathy in patient with
pSS, and her renal disease anteceded the onset of subjec-
tive sicca syndrome.References
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